hemodialysis
Procedure3 times per week
NCT Number: NCT00694031
Patients on hemodialysis will be randomly assigned (1:1) to continue on conventional hemodialysis or on-line hemodiafiltration, both three times per week. A 3 year follow-up and a sample size of around 750 will be necessary to detect a 35% reduction in mortality.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Hospital Clinic de Barcelona, Barcelona, Spain
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
3 times per week
3 times per week
Time frame: 36 months
Looking for future studies?
Notify MeHospital Clinic of Barcelona
Other
A Randomized Study to Evaluate Survival in Patients Undergoing Hemodialysis or On-line Hemodiafiltration
Acronym: ESHOL
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07842939
Difficult Vascular Access Cannulation, Hemodialysis
Kaohsiung City, Taiwan
View Trial DetailsNCT07183696
Hemodialysis
Giza, Egypt
View Trial DetailsNCT07076888
Hemodialysis
Cairo, Egypt
View Trial DetailsNCT07814469
Dyssomnias, Hemodialysis
Alexandria, Alexandria Governorate, Egypt
View Trial Details